Exchange: OTC Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
0.87% $0.727
America/New_York / 3 mai 2024 @ 15:48
FUNDAMENTALS | |
---|---|
MarketCap: | 142.87 mill |
EPS: | -0.330 |
P/E: | -2.20 |
Earnings Date: | May 09, 2024 |
SharesOutstanding: | 196.64 mill |
Avg Daily Volume: | 0.314 mill |
RATING 2024-05-03 |
---|
C+ |
Sell |
RATINGS | ||
---|---|---|
Rating CashFlow: | Sell | |
Return On Equity: | Strong Buy | |
Return On Asset: | Sell | |
DE: | Strong Sell | |
P/E: | Sell | |
Price To Book: | Strong Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -2.20 | sector: PE 29.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
-0.07x |
Company: PE -2.20 | industry: PE 31.46 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 0.649 - 0.805 ( +/- 10.74%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-17 | Cacioppo James | Buy | 3 000 000 | Stock Option (right to buy) |
2023-12-17 | Cacioppo James | Buy | 718 750 | Warrant (right to buy) |
2023-12-17 | Barack Louis Jon | Buy | 1 000 000 | Stock Option (right to buy) |
2023-12-17 | Lebowitz Tobi | Buy | 300 000 | Stock Option (right to buy) |
2023-12-17 | Lebowitz Tobi | Buy | 165 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
5.22 |
Last 80 transactions |
Buy: 19 977 067 | Sell: 47 069 433 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $0.727 (0.87% ) |
Volume | 0.105 mill |
Avg. Vol. | 0.314 mill |
% of Avg. Vol | 33.55 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of medical and adult-use products. It focuses on building a portfolio of cannabis assets in various jurisdictions in Pennsylvania, Virginia, Ohio, Illinois, California, Nevada, and Massachusetts. The company also offers hemp-based CBD products, including cannabidiol supplements, tinctures, capsules, softgels, and topicals under The Bank, The Lab, Nira+ Medicinals, Seche, Tasteology, and Nira brands. As of June 6, 2022, it operated 33 BEYOND/HELLO retail locations. The company was incorporated in 2007 and is headquartered in Boca Raton, Florida.